Ocrevus (ocrelizumab) and Tysabri (natalizumab) appear equally effective at controlling relapses and MS progression, a study finds.

Having parents with a history of smoking is associated with a significantly increased risk of developing pediatric MS, a ...

Researchers mapped myelin-making cells in mice, showing some brain regions recover better after myelin damage.

An energy boost following her breakup with coffee reminds columnist Susan Payrovi, MD. to focus on clean, renewable sources of energy.

MS Awareness Month brings advocacy campaigns, educational events, and fundraisers as organizations spotlight resources for people with MS.

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and other conditions.

For years, columnist Ben Hofmeister avoided talking about his invisible scars caused by the silent challenges of life with MS.

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

A collaboration will test whether changes in a person’s voice can help detect multiple sclerosis, potentially enabling a ...

Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when started earlier.

After struggling during seasons when MS took center stage, columnist Ahna Crum is enjoying the quieter days where it's only ...

A new community-led network called PRADA enables underrepresented patients living with MS to help set research priorities.